Crohn’s diseasebiological therapy
…evelop and evaluate a machine learning (ML) model that predicts Crohn’s disease (CD) patients responsible for the top quartile of healthcare sp…
172articles mentioning diseases
273disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: crohn’s disease ×
crohn’s disease
This disease is selected. Its supporting articles are shown below.
Articles mentioning crohn’s disease
172 articles · page 12 of 15ulcerative colitisCrohn’s diseaseIBDCDUCpaediatric inflammatory bowel diseaseHungarian Pediatric IBD Registry
…ry (2010–2020), including children with Crohn’s disease (CD) or ulcerative colitis (UC). Outcomes (relapse, steroid dependency, biological therapy…
Crohn’s diseasemedical treatment
…MRE) are state-of-the-art modalities recommended for monitoring Crohn’s disease (CD) activity and treatment response. This study aimed to exami…
92.0%
Crohn’s diseaseIdiopathic achalasia
…enetic risk. In addition, IA shows a shared aetiopathology with Crohn’s disease (rg=0.335). Integrating GWAS and single-cell RNA-sequencing dat…
Crohn’s diseaseCDfaecal calprotectinDai et al
…etter regarding our recent study defining preclinical stages of Crohn’s disease (CD) using faecal calprotectin in asymptomatic first-degree rel…
Inflammatory bowel diseaseCrohn’s disease
…Background Inflammatory bowel disease is characterised by progressive epithelial, immune and stromal …
Crohn’s diseaseCDfaecal calprotectinGut
… the use of faecal calprotectin to define preclinical stages of Crohn’s disease (CD) in asymptomatic first-degree relatives (FDRs) of patients …
Perianal fistulising diseaseCrohn’s diseasesurgical approachesGudiño et al
…Perianal fistulising disease (PFD) remains one of the most disabling complications of Crohn’…
Crohn’s diseaseCDFaecal calprotectinTasty&Healthy dietCalprotectin
…ial evaluates whether the Tasty&Healthy diet can reduce risk of Crohn’s disease (CD) development in first-degree relatives (FDRs). The optimal …
Crohn’s diseaseantimicrobials
…invasive Escherichia coli (AIEC), in the ileum of patients with Crohn’s disease (CD), that was genetically distinct from diarrheagenic E. coli,…
92.5%
Crohn’s diseaseCDRisankizumabustekinumabustekinumab-naiveustekinumab-exposedUK licensing authorities
…nterleukin-23 p19 subunit inhibitor which received approval for Crohn’s disease (CD) by UK licensing authorities in May 2023. Our aim was to ev…
inflammatory bowel diseaseulcerative colitisCrohn’s diseaseustekinumabvedolizumabVDZThe Medical Research Ethics CommitteeDanish Medicines AgencyUST
…Z) and ustekinumab (UST), offer effective treatment options for inflammatory bowel disease. In spite of limited evidence, it is common practice to escalat…